Centiva Capital LP Makes New $306,000 Investment in Oscar Health, Inc. (NYSE:OSCR)

Centiva Capital LP bought a new stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 22,741 shares of the company's stock, valued at approximately $306,000.

A number of other hedge funds have also recently modified their holdings of OSCR. Tower Research Capital LLC TRC grew its stake in Oscar Health by 171.4% during the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock valued at $89,000 after acquiring an additional 4,185 shares in the last quarter. KBC Group NV increased its holdings in Oscar Health by 56.1% in the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock worth $96,000 after acquiring an additional 2,555 shares in the last quarter. Alberta Investment Management Corp purchased a new stake in shares of Oscar Health during the fourth quarter worth $138,000. Virtu Financial LLC acquired a new position in Oscar Health in the fourth quarter valued at about $140,000. Finally, Potentia Wealth acquired a new stake in shares of Oscar Health during the fourth quarter worth about $141,000. Hedge funds and other institutional investors own 75.70% of the company's stock.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their target price for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Two analysts have rated the stock with a sell rating, two have given a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $20.08.

Oscar Health Stock Performance

Shares of NYSE OSCR traded up $0.96 during trading hours on Friday, reaching $17.52. The stock had a trading volume of 10,504,285 shares, compared to its average volume of 4,198,809. The business's fifty day moving average is $13.46 and its two-hundred day moving average is $14.63. Oscar Health, Inc. has a twelve month low of $11.20 and a twelve month high of $23.79. The company has a market cap of $4.39 billion, a price-to-earnings ratio of -875.31 and a beta of 1.75. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.83 by $0.09. The company had revenue of $3 billion for the quarter, compared to analysts' expectations of $2.87 billion. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The business's revenue for the quarter was up 42.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.62 earnings per share. As a group, research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Insider Activity at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the transaction, the director now directly owns 64,512 shares in the company, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 24.39% of the stock is owned by insiders.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.